This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Comprehensive chemical profiling of two Dendrobium species and identification of anti-hepatoma active constituents from Dendrobium chrysotoxum by network pharmacology
BMC Complementary Medicine and Therapies Open Access 01 July 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Jin, H. et al. EGFR activation limits the response of liver cancer to lenvatinib. Nature 595, 730–734 (2021)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hindson, J. Lenvatinib plus EGFR inhibition for liver cancer. Nat Rev Gastroenterol Hepatol 18, 675 (2021). https://doi.org/10.1038/s41575-021-00513-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41575-021-00513-6
This article is cited by
-
Comprehensive chemical profiling of two Dendrobium species and identification of anti-hepatoma active constituents from Dendrobium chrysotoxum by network pharmacology
BMC Complementary Medicine and Therapies (2023)